Press release
Aorto-Iliac Occlusive Disease Treatment Market Projected to Reach USD 3.56 Billion by 2034, Expanding at a CAGR of 5.3%
Aorto-Iliac Occlusive Disease Treatment Market
The report analyzes the market for aorto-iliac occlusive disease treatment to register a CAGR of 5.3% during 2025-2034. The market was valued at USD 2.12 billion in 2024 and is anticipated to reach USD 3.56 billion by 2034.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/aorto-iliac-occlusive-disease-treatment-market/request-for-sample
Market Overview:
Aorto-iliac occlusive disease (AIOD) treatment focuses on restoring adequate blood flow in patients with narrowing or blockage of the aorta and iliac arteries. This condition is typically caused by atherosclerosis, which is plaque buildup that reduces arterial blood flow. Treatment options vary based on the severity of the disease and the overall health of the patient. In the early stages, conservative management includes lifestyle modifications such as smoking cessation, structured exercise programs, and the use of medications. For more severe cases, minimally invasive endovascular procedures such as angioplasty are commonly used to open narrowed arteries. In patients with extensive occlusions surgical revascularization, like aorto-bifemoral bypass grafting, may be performed.
Market Dynamics:
Rising Prevalence of Peripheral Arterial Disease (PAD): The rising number of people being affected by lifestyle-related conditions such as high blood pressure, diabetes, and obesity has led to a higher risk of peripheral arterial disease (PAD. These health issues lead to damaged blood vessels over time, making individuals more prone to blockages in major arteries. As a result, more patients are being diagnosed with aorto-iliac occlusive disease. This is creating higher demand for effective treatment options and driving the aorto-iliac occlusive disease treatment market forward.
Growing Geriatric Population: The rising proportion of older adults globally has led to an increase in aorto-iliac occlusive disease cases. Older adults naturally experience wear and tear in their blood vessels. This makes them more vulnerable to arterial blockages and other associated complications. This population group often requires regular check-ups and interventional procedures for effective management of their conditions. Thus, the rising geriatric population is fueling the demand for aorto-iliac occlusive disease treatment.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/aorto-iliac-occlusive-disease-treatment-market/request-for-discount-pricing
Market Key Players:
The competitive landscape of the aorto-iliac occlusive disease treatment market is characterized by rising collaborations and innovation-led growth. Players are focusing on strategic initiatives to improve their market positioning. A few of the major market participants are:
• Abbott
• BD.
• Bentley InnoMed
• Biotronik SE & Co KG
• Boston Scientific Corporation
• Cook
• Getinge AB
• iVascular
• Medtronic
• Scitech Medical
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Aorto-Iliac Occlusive Disease Treatment Industry Developments
• March 2024: Cook Medical entered into a distribution agreement with Getinge to enhance access to the iCast covered stent system in the United States. The device is used in the treatment of iliac artery disease, supporting improved patient care and availability.
• January 2024: Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval from China's National Medical Products Administration (NMPA) for its ZYLOX Peripheral Venous Stent System. This system is designed to treat lower limb and pelvic venous disorders associated with iliac vein compression.
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/aorto-iliac-occlusive-disease-treatment-market
Market Segmentation:
By Device Type Outlook (Revenue, USD Billion, 2020-2034)
• Endovascular Devices
o Balloon Angioplasty Devices
o Atherectomy Systems
o Stents
• Surgical Devices
By Procedure Outlook (Revenue, USD Billion, 2020-2034)
• Endovascular Procedures
• Hybrid Procedures
• Open Surgical Procedures
By End Use Outlook (Revenue, USD Billion, 2020-2034)
• Hospitals
• Outpatient Facilities
• Others
Regional Analysis
North America accounted for a significant market share in 2024. This is primarily due to the region's strong reimbursement frameworks and widespread use of advanced endovascular procedures. The presence of a well-established healthcare infrastructure further contributes to the region's major market share.
Asia Pacific is projected to register the highest CAGR from 2025 to 2034, driven by expanding medical infrastructure, rising healthcare access, and growing awareness of vascular conditions. The growing aging population and improved affordability of healthcare services further drive robust market growth in the region.
Browse More Research Reports:
MENA Gaucher Disease Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/middle-east-and-north-america-mena-gaucher-disease-treatment-market
Coagulation analyzer market:
https://www.polarismarketresearch.com/industry-analysis/coagulation-analyzer-market
Coagulation Reagent Market:
https://www.polarismarketresearch.com/industry-analysis/coagulation-reagent-market
Direct Oral Anticoagulants (DOACs) Device Market:
https://www.polarismarketresearch.com/industry-analysis/direct-oral-anticoagulants-doacs-device-market
Molecular Diagnostics For Sexually Transmitted Diseases Market:
https://www.polarismarketresearch.com/industry-analysis/molecular-diagnostics-for-sexually-transmitted-diseases-market
Topical Drugs Cdmo Market:
https://www.polarismarketresearch.com/industry-analysis/topical-drugs-cdmo-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aorto-Iliac Occlusive Disease Treatment Market Projected to Reach USD 3.56 Billion by 2034, Expanding at a CAGR of 5.3% here
News-ID: 4081215 • Views: …
More Releases from Polaris Market Research & Consulting
Algae-Based Sustainable Aviation Fuel (SAF) Market to Reach USD 844.98 Million b …
Polaris Market Research announces the release of its latest research report titled "Algae-Based Sustainable Aviation Fuel (SAF) Market Size, Share, Industry Analysis Report By Feedstock Type (Microalgae and Macroalgae), By Production Technology, By Blend Level, By Distribution Channel, By Application, and By Region - Market Forecast, 2025-2034."
The report analyzes the market for algae-based sustainable aviation fuel to register a CAGR of 27.7% from 2025-2034. The market was valued at…
Projected Growth: Sterilization Services Market to Reach USD 7,352.39 Million by …
Sterilization Services Market
The sterilization services market report by Polaris Market Research offers an in-depth assessment of the rapidly evolving sector. It covers all the key market aspects, including market share, size, trends, and recent developments. In addition, an assessment of the top segments, key regions, and competitive landscape has been provided in the report.
The report analyzes the market for sterilization services to register a CAGR of 7.6% during 2025-2034.…
Radiation Therapy in the Oncology Market on Track to Hit USD 15.43 Billion by 20 …
Radiation Therapy in the Oncology Market
The radiation therapy in the oncology market report by Polaris Market Research offers an in-depth assessment of the rapidly evolving sector. It covers all the key market aspects, including market share, size, trends, and recent developments. In addition, an assessment of the key regions, top segments, and competitive landscape has been provided.
The report analyzes the market for radiation therapy in oncology to register a CAGR…
Kidney Preservation Market Projected to Reach USD 117.86 Million by 2034 | CAGR: …
The kidney preservation market is projected to reach USD 117.86 million by 2034, expanding at a CAGR of 6.8% from 2025 to 2034. The market was valued at USD 61.19 million in 2024. The market is largely driven by the growing prevalence of chronic and end-stage renal disease, leading to a significant rise in the demand for kidney transplants.
Kidney preservation is the process of maintaining a donated kidney's viability between…
More Releases for Disease
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,…
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
